Document Detail

Electroconvulsive therapy in patients with vagus nerve stimulation.
MedLine Citation:
PMID:  18665100     Owner:  NLM     Status:  MEDLINE    
Numerous studies have demonstrated the safety and efficacy of electroconvulsive therapy (ECT) for various psychiatric conditions, and it has been approved by the Food and Drug Administration for the treatment of refractory depression. Recently, the Food and Drug Administration also approved vagus nerve stimulation as a treatment for chronic or recurrent depression. Although electrical stimulation is used for both ECT and vagus nerve stimulation, the mechanisms of their action are very different. The American Psychiatric Association task force identifies no absolute contraindications to the use of ECT. The authors present 2 interesting cases of successful ECT in combination with vagus nerve stimulator.
Ashish Sharma; Rajeev Chaturvedi; Arun Sharma; James H Sorrell
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The journal of ECT     Volume:  25     ISSN:  1533-4112     ISO Abbreviation:  J ECT     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-04     Completed Date:  2009-08-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9808943     Medline TA:  J ECT     Country:  United States    
Other Details:
Languages:  eng     Pagination:  141-3     Citation Subset:  IM    
Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68198-8470, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alcoholism / complications,  psychology,  therapy
Depressive Disorder, Major / psychology,  therapy*
Electric Stimulation Therapy*
Electroconvulsive Therapy*
Middle Aged
Psychiatric Status Rating Scales
Stress Disorders, Post-Traumatic / psychology,  therapy
Suicide / psychology
Vagus Nerve / physiology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic value of double product reserve.
Next Document:  Remifentanil/Thiopental combination and seizure length in electroconvulsive therapy.